An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
Clinical trial NCT02265510 · TERMINATED
Trial details
- NCT number
- NCT02265510
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-10
- Primary completion
- 2019-02-27
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.